Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Asia-Pacific Journal of Clinical Oncology|March 3, 2022
A new prognostic model including platelet/lymphocyte ratio and International Prognostic Score 3 for freedom from progression in patients with previously untreated advanced classical Hodgkin lymphomaYunxia Tao, Haizhu Chen, Yu Zhou, et al.
Cancer Innovation|April 14, 2026
Treatment Outcomes With Novel Targeted and Immunotherapeutic Regimens in CAYA Hodgkin Lymphoma: A Retrospective StudyMengqing Xie, Meng Yuan, Mengwei Ren, et al.
Cancer Management and Research|November 18, 2020
Characteristics and Management of TP53-Mutated Diffuse Large B-Cell Lymphoma PatientsYan Qin, Shiyu Jiang, Peng Liu, et al.
Asia-Pacific Journal of Clinical Oncology|July 13, 2022
The clinical features, treatment, and prognostic factors for peripheral T-cell lymphomas: A single-institution analysis of 240 Chinese patientsHaizhu Chen, Yunxia Tao, Yu Zhou, et al.
BMC Cancer|May 27, 2022
Enhancement of the International prognostic index with β2-microglobulin, platelet count and red blood cell distribution width: a new prognostic model for diffuse large B-cell lymphoma in the rituximab eraHaizhu Chen, Qiaofeng Zhong, Yu Zhou, et al.
Future Oncology (London, England)|February 18, 2022
Prognostic role of red blood cell distribution width and platelet/lymphocyte ratio in early-stage classical Hodgkin lymphomaYunxia Tao, Yu Zhou, Haizhu Chen, et al.
Leukemia Research|October 8, 2014
The prognostic utility and the association of serum light chains (free and total) and absolute lymphocyte count in patients with newly diagnosed diffuse large B-cell lymphomaXiaohong Han, Jianfei Wang, Ningning Zhang, et al.
Asia-Pacific Journal of Clinical Oncology|August 12, 2020
R-CHOP immunochemotherapy plus surgery is associated with a superior prognosis in Chinese primary intestinal diffuse large B-cell lymphomaFengyi Zhao, Yan Qin, Jianliang Yang, et al.
Journal of Cancer Research and Clinical Oncology|April 24, 2023
MYD88L265P and MYD88other variants show different molecular characteristics and prognostic significance in diffuse large B-cell lymphomaYan Qin, Tian Qiu, Zucheng Xie, et al.
Targeted Oncology|April 3, 2020
Genomic Alterations and MYD88MUT Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to IbrutinibShiyu Jiang, Yan Qin, Lin Gui, et al.
Pageof 10